한국간담췌외과학회지 (Annals of Hepato-Biliary-Pancreatic Surgery)

  • 제28권1호
  • /
  • Pages.80-91
  • /
  • 2024
  • /
  • 2508-5778(pISSN)
  • /
  • 2508-5859(eISSN)
한국간담췌외과학회 (The Korean Association of Hepato-Biliary-Pancreatic Surgery)
권호 표지
DOI QR코드

DOI QR Code

Postoperative fluid therapy in enhanced recovery after surgery for pancreaticoduodenectomy

  • Sharnice Koek (Department of General Surgery, Fiona Stanley Hospital) ;
  • Johnny Lo (School of Science, Edith Cowan University) ;
  • Rupert Ledger (Department of Anaesthesia and Pain Medicine, Fiona Stanley Hospital) ;
  • Mohammed Ballal (Department of General Surgery, Fiona Stanley Hospital)
  • 투고 : 2023.06.30
  • 심사 : 2023.08.30
  • 발행 : 2024.02.29
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Backgrounds/Aims: Optimal intravenous fluid management during the perioperative period for patients undergoing pancreaticoduodenectomy (PD) within the framework of enhanced recovery after surgery (ERAS) is unclear. Studies have indicated that excessive total body salt and water can contribute to the development of oedema, leading to increased morbidity and extended hospital stays. This study aimed to assess the effects of an intravenous therapy regimen during postoperative day (POD) 0 to 2 in PD patients within ERAS. Methods: A retrospective interventional cohort study was conducted, and it involved all PD patients before and after implementation of ERAS (2009-2017). In the ERAS group, a targeted maintenance fluid regimen of 20 mL/kg/day with a sodium requirement of 0.5 mmoL/kg/day was administered. Outcome measures included the mmol of sodium and chloride administered, length of stay, and morbidity (postoperative pancreatic fistula, POPF; acute kidney injury, AKI; ileus). Results: The study included 169 patients, with a mean age of 64 ± 11.3 years. Following implementation of the intravenous fluid therapy protocol, there was a significant reduction in chloride and sodium loading. However, in the multivariable analysis, chloride administered (mmoL/kg) did not independently influence the length of stay; or rates of POPF, ileus, or AKI (p > 0.05). Conclusions: The findings suggested that a postoperative intravenous fluid therapy regimen did not significantly impact morbidity. Notably, there was a trend towards reduced length of stay within an increasingly comorbid patient cohort. This targeted fluid regimen appears to be safe for PD patients within the ERAS program. Further prospective research is needed to explore this area.

키워드

참고문헌

  1. Australian Institute of Health and Welfare (AIHW). AIHW statistical information system [Internet]. AIHW 2016 [cited 2023 Jul 1]. Available from: https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia/contents/rankings.
  2. Salem AI, Alfi M, Winslow E, Clifford SC, Weber SM. Has survival following pancreaticoduodenectomy for pancreas adenocarcinoma improved over time? J Surg Oncol 2015;112:643649.
  3. Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 2006;10:1199-1210.
  4. Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery (ERAS): a review. JAMA Surg 2017;152:292-298.
  5. Weinberg L, Wong D, Karalapillai D, Pearce B, Tan CO, Tay S, Christophi C, et al. The impact of fluid intervention on complications and length of hospital stay after pancreaticoduodenectomy (Whipple's procedure). BMC Anesthesiol 2014;14:35.
  6. Lobo DN. Fluid overload and surgical outcome: another piece in the jigsaw. Ann Surg 2009;249:186-188.
  7. Myles PS, Bellomo R, Corcoran T, Forbes A, Peyton P, Story D, et al. Restrictive versus liberal fluid therapy for major abdominal surgery. N Engl J Med 2018;378:2263-2274.
  8. Gustafsson UO, Scott MJ, Schwenk W, Demartines N, Roulin D, Francis N, et al. Guidelines for Perioperative Care in Elective Colonic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations. World J Surg 2013;37:259-284.
  9. McCluskey SA, Karkouti K, Wijeysundera D, Minkovich L, Tait G, Beattie WS. Hyperchloremia after noncardiac surgery is independently associated with increased morbidity and mortality. Anesth Analg 2013;117:412-421.
  10. Bennett VA, Cecconi M. Perioperative fluid management: from physiology to improving clinical outcomes. Indian J Anaesth 2017;61:614-621.
  11. Navarro LH, Bloomstone JA, Auler JO Jr, Cannesson M, Rocca GD, Gan TJ, et al. Perioperative fluid therapy: a statement from the international Fluid Optimization Group. Perioper Med (Lond) 2015;4:3.
  12. Pearse RM, Harrison DA, MacDonald N, Gillies MA, Blunt M, Ackland G, et al. Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery. JAMA 2014;311:2181-2190.
  13. Kulemann B, Fritz M, Glatz T, Marjanovic G, Sick O, Hopt UT, et al. Complications after pancreaticoduodenectomy are associated with higher amounts of intra- and postoperative fluid therapy: a single center retrospective cohort study. Ann Med Surg (Lond) 2017;16:23-29.
  14. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research Electronic Data Capture (REDCap) -- a metadata driven methodology and workflow process for providing translational research informatict support. J Biomed Inform 2009;42:377-381.
  15. Dindo D, Demartines N, Clavien PA. Classification of surgical complications. Ann Surg 2004;240:205-213.
  16. Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery 2017;161:584-591.
  17. Kellum JA, Lameire N, KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 2013;17:204.
  18. Prien T, Backhaus N, Pelster F, Pircher W, Bunte H, Lawin P. Effect of intraoperative fluid administration and colloid osmotic pressure on the formation of intestinal edema during gastrointestinal surgery. J Clin Anesth 1990;2:317-323.
  19. Huang Y, Chua TC, Gill AJ, Samra JS. Impact of perioperative fluid administration on early outcomes after pancreatoduodenectomy: a meta-analysis. Pancreatology 2017;17:334-341.
  20. Sulzer JK, Sastry AV, Meyer LM, Cochran A, Buhrman WC, Baker EH, et al. The impact of intraoperative goal-directed fluid therapy on complications after pancreaticoduodenectomy. Ann Med Surg 2018;36:23-28.
  21. Koek SA, Ballal MS. Impelmentation of ERAS in pancreaticoduodenectomy in an Australian tertiary centre. Pancreatology 2023;23:729-735.
  22. Thiele RH, Rea KM, Turrentine FE, Friel CM, Hassinger TE, McMurry TL, et al. Standardization of care: impact of an enhanced recovery protocol on length of stay, complications, and direct costs after colorectal surgery. J Am Coll Surg 2015;220:430443.
  23. Miller TE, Roche AM, Mythen M. Fluid management and goal-directed therapy as an adjunct to Enhanced Recovery After Surgery (ERAS). Can J Anesth 2015;62:158-168.